Diabetes and Parkinson's Disease - Stem Cells May Make Treatment Possible

Parkinson's disease (PD) is a degenerative disorderand led to functional recovery in eight of nine rats.
affecting the central nerve system. A person withImportantly, no cancers that might have been caused
Parkinson's disease may develop muscular rigidity,by the transplants were detected up to eight weeks
tremors, and altered speech patterns. The personfollowing transplantation.
may also have problems using language and loseAn additional remarkable study was reported recently
higher cognitive functions. PD may cause a person toby Zhou et al.2 at the Harvard Stem Cell Institute.
move very slowly (bradykinesia) and may cause lossUsing an in vivo approach in adult mice, this team
of balance. The disease is progressive and chronic. PDdirectly converted mouse pancreatic exocrine cells
is not fatal, but eventually severe muscular problemsinto pancreatic endocrine β-cells. The team used
may cause pneumonia, choking, and falls which mayan adenovirus to transfect the exocrine cells with a
result in death. PD affects approximately 150 out ofspecific combination of transcription factors,
every 100,000 Caucasian individuals, and is slightly lesseffectively reprogramming the exocrine cells into
prevalent among African-Americans.endocrine β-cells. This stunning breakthrough
Parkinson's disease is caused by decreased activity ofdemonstrates that it is possible in certain
dopamine (DA)-secreting nerve cells located in thecircumstances to avoid the necessity of
substantia nigra ("black substance") of the brain. DA isreprogramming a cell to an embryonic pluripotent
a neurotransmitter involved in the regulation ofstate. Zhou et al showed that transdifferentiation is
muscular activity as well as various neuropsychiatricpossible by using a cocktail of lineage-specific
functions including cognition and behavior. A commontranscription factors.
medical treatment for PD is L-Dopa which isMuch work is needed to be done, of course. Yet the
converted into DA by dopaminergic neurons in thework of both these research teams points to
substantia nigra. Administration of L-Dopa attemptsexciting new possibilities for treatment of these
to replace the body's supply of DA. The drug is notdevastating diseases.
an optimal therapy - only a small percentage isThe field of regenerative medicine is progressing at
converted to DA and the drug causes manyan astonishing rate. Hallowed concepts of embryology
side-effects.and development are being revised, practically
PD is an ideal candidate for stem cell treatment.on-the-fly, yearly if not monthly. We are living in very
Brilliant research by Wernig et al.1 (conducted in theexciting times.
Jaenisch laboratory at the Whitehead Institute for1 Wernig M, et al: Neurons derived from
Biomedical Research) demonstrated successfulreprogrammed fibroblasts functionally integrate into
treatment of PD in adult rats using neurons derivedthe fetal brain and improve symptoms of rats with
from stem cells. These authors derived iPS cells byParkinson's disease. Proc Natl Acad Sci USA
reprogramming rat connective tissue cells. The stem105(15):5856-5861, 2008
cells were then transformed into neuronal cell types2 Zhou Q, et al: In vivo reprogramming of adult
and transplanted into the brains of adult rat modelspancreatic exocrine cells to beta-cells.
of PD. The nerve cells were successfully transplanted